Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities

Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities

Background: Plasma IL-6 and YKL-40 are prognostic biomarkers for OS in patients with different types of solid tumors, but they have not been studied in patients before surgery of metastatic bone disease (MBD) of the extremities. The aim was to evaluate the prognostic value of plasma IL-6 and YKL-40...

Full description

Bibliographic Details
Main Authors: Michala Skovlund Sørensen, Thomas Colding-Rasmussen, Peter Frederik Horstmann, Klaus Hindsø, Christian Dehlendorff, Julia Sidenius Johansen, Michael Mørk Petersen
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
bone metastases
inflammatory response
IL-6
prognostic biomarkers
YKL-40
Online Access:https://www.mdpi.com/2072-6694/13/11/2833

Internet

https://www.mdpi.com/2072-6694/13/11/2833

Similar Items